New Results
Immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics
View ORCID ProfileMaria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, View ORCID ProfileFlorian Erhard, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Irene Braña, Eva Muñoz-Couselo, Elena Garralda, Andreas Schlosser, Alena Gros
doi: https://doi.org/10.1101/2022.11.07.514886
Maria Lozano-Rabella
1Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Andrea Garcia-Garijo
1Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Jara Palomero
1Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Anna Yuste-Estevanez
1Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Florian Erhard
2Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Germany
Juan Martín-Liberal
3Early Drug Development Unit (UITM) Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Maria Ochoa de Olza
3Early Drug Development Unit (UITM) Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Ignacio Matos
3Early Drug Development Unit (UITM) Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Jared J. Gartner
4Surgery Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA
Michael Ghosh
5Institute for Cell Biology Department of Immunology, University of Tübingen, Germany
Francesc Canals
6Proteomics, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
August Vidal
7Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL. CIBERONC
Josep Maria Piulats
8Medical Oncology, Catalan Institute of Cancer (ICO), IDIBELL-Oncobell, Hospitalet de Llobregat, Spain
Xavier Matias-Guiu
7Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL. CIBERONC
Irene Braña
3Early Drug Development Unit (UITM) Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Eva Muñoz-Couselo
9Melanoma and other skin tumors unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital
Elena Garralda
3Early Drug Development Unit (UITM) Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Andreas Schlosser
2Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Germany
Alena Gros
1Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital, Barcelona, Spain
Posted November 07, 2022.
Immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Irene Braña, Eva Muñoz-Couselo, Elena Garralda, Andreas Schlosser, Alena Gros
bioRxiv 2022.11.07.514886; doi: https://doi.org/10.1101/2022.11.07.514886
Immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Irene Braña, Eva Muñoz-Couselo, Elena Garralda, Andreas Schlosser, Alena Gros
bioRxiv 2022.11.07.514886; doi: https://doi.org/10.1101/2022.11.07.514886
Subject Area
Subject Areas
- Biochemistry (11700)
- Bioengineering (8715)
- Bioinformatics (29120)
- Biophysics (14927)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14140)
- Epidemiology (2067)
- Evolutionary Biology (18262)
- Genetics (12216)
- Genomics (16761)
- Immunology (11840)
- Microbiology (27999)
- Molecular Biology (11549)
- Neuroscience (60784)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4937)
- Plant Biology (10382)
- Synthetic Biology (2876)
- Systems Biology (7332)
- Zoology (1642)